August, 2023

article thumbnail

Number of advanced pharmacist roles in general practice doubles in a year

The Pharmacist

The number of advanced pharmacist practitioner roles in general practice in England has nearly doubled in the last year, while the number of pharmacists has remained consistent. The increase in advanced roles has brought the total number of full-time equivalent (FTE) pharmacist roles in general practice to 2,000 as of July 2023, once both roles […] The post Number of advanced pharmacist roles in general practice doubles in a year appeared first on The Pharmacist.

114
114
article thumbnail

Cybersecurity dominates pharma industry discussions during Q2 2023: GlobalData

Express Pharma

Amid the push for digital transformation, the pharma industry finds itself navigating a critical intersection of concerns—data protection, regulations, and the threat of data breaches. This pivotal juncture has thrust cybersecurity into the spotlight in the discussions of companies during Q2 2023, revealing its paramount significance in safeguarding sensitive information, with regulation mentions getting on par with data protection, reveals the Company Filing Analytics Database of GlobalData.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Stem cell therapy delivers potential for sickle cell disease

European Pharmaceutical Review

New research published in the New England Journal of Medicine has indicated that stem cell gene therapy could provide a curative treatment for sickle cell disease (SCD). Based on new data from the Novartis Phase I/II clinical trial , which used the first therapy to target a new genetic area and use cryopreserved stem cells, trial participants reported a decrease in vaso-occlusive events.

Hospitals 111
article thumbnail

STAT+: One dose of psilocybin may have lasting effects on major depression, study finds

STAT

A single dose of psilocybin may have enduring benefits for people with major depressive disorder, according to a randomized clinical trial published Thursday in the Journal of the American Medical Association. Several prior studies have suggested that psilocybin, the psychedelic compound produced by certain types of mushrooms, could be a promising way to treat major depression in people for whom antidepressants or counseling aren’t effective.

article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

‘We need to do better:’ A biotech CEO on standing apart from the crowd

PharmaVoice

The CEO of Cullinan Oncology is taking a small biotech to the next step and believes the temporary financial barriers are smaller than scientific progress.

264
264

More Trending

article thumbnail

UCB announces approval of Bimzelx

Pharma Times

The therapy is used to treat patients with psoriatic arthritis and axial spondyloarthritis - News - PharmaTimes

165
165
article thumbnail

CPE slams 'shambolic' vaccination U-turn despite additional funding

The Pharmacist

Community pharmacies will get additional payments to deliver Covid vaccinations in September and October as the government brings forward the autumn programme in light of a new Covid variant. But the sector’s negotiator has criticised the government’s ‘shambolic start’ to the vaccination programme, which it said has a ‘seemingly endlessly changing timetable’ that leaves community […] The post CPE slams 'shambolic' vaccination U-turn despite additional funding appeared first on Th

Vaccines 126
article thumbnail

Medicare names first 10 drugs for price negotiations

BioPharma Dive

The list includes the top-selling blood thinners Eliquis and Xarelto, as well as the arthritis drug Enbrel and heart failure medicine Entresto.

120
120
article thumbnail

No longer brushed off: A Minnesota clinic tries to rewrite medicine’s approach to miscarriage

STAT

WOODBURY, Minn. — By the time Taylor Teske came to be sitting on an exam table in an obstetrician’s office in Minnesota, her medical records marked a devastating journey: nine pregnancies, one baby, eight miscarriages. The first miscarriage happened in June 2018, almost as soon as she found out she was pregnant. Teske told her boss at the vascular clinic where she worked that she was pregnant, and he asked if she wanted to sneak a look using the clinic’s ultrasound.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

A rare disease research aims to tackle disability discrimination in new lawsuit

PharmaVoice

How a pediatric neurologist is advocating for herself and the disabled community in a legal battle with the Howard Hughes Medical Institute.

246
246
article thumbnail

SAEM Clinical Images Series: Back Yard Football Injury

ALiEM - Pharm Pearls

A 10-year-old male with no past medical history presents to the Emergency Department (ED) by EMS for evaluation of an injury sustained while playing tackle football. The patient was forcibly hit by another child against a tree. He complains of sharp right shoulder and chest pain that worsens with movement of his right upper extremity and he arrives wearing a sling to immobilize the arm.

246
246
article thumbnail

BenevolentAI doses participants in BEN-8744 study

Pharma Times

The candidate is a peripherally restricted small-molecule PDE10 inhibitor to treat ulcerative colitis - News - PharmaTimes

160
160
article thumbnail

China’s CanSino seeks more vaccine contracts after AstraZenca deal

Express Pharma

CanSino begun researching mRNA technology in 2018 and has built a facility in Shanghai that can produce up to 200 million doses a year China’s CanSino Biologics , which recently announced a contract manufacturing deal to support AstraZenca’s messenger RNA (mRNA) technology vaccine programme, is in talks with more firms on similar deals, its CEO said, as it seeks new revenue streams to make up for plummeting COVID vaccine demand.

Vaccines 115
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Sanofi appoints a venture investor to R&D head as executive team expands

BioPharma Dive

Houman Ashrafian, currently a scientific advisor at SV Health Investors, will fill the role left by John Reed, who oversaw the transformation of research and development during his five years at Sanofi.

120
120
article thumbnail

STAT+: As pharmaceutical companies bemoan Medicare’s drug negotiations, hospitals and doctors stay mum

STAT

The pharmaceutical industry has been up in arms over Medicare’s first list of 10 prescription drugs that will be subject to negotiations. But other major parts of the health care industry — hospitals, doctors, and other providers — have refrained from either lending support or criticizing the government’s process. The American Hospital Association, the industry’s main lobbying group, told STAT it is “not commenting on this issue right now.

Hospitals 362
article thumbnail

Brii Biosciences aims to come up big where Sage and Biogen fell short

PharmaVoice

The depression space recently got a stinging FDA rebuke — but Brii thinks it can break through with improved formulations.

246
246
article thumbnail

SAEM Clinical Images Series: There’s a Stone Under My Tongue

ALiEM - Pharm Pearls

A 44-year-old female presented to the emergency department with the complaint of a “stone under [her] tongue.” She reported that the “stone” had been present and painless for two years. The day prior, she began experiencing pain at this site while brushing her teeth. She squeezed the area in an attempt to expel it, but this action only increased her pain.

Hospitals 130
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

FDA grants Orphan Drug Designation to Faron’s bexmarilimab in AML

Pharma Times

The ODD will offer clinical development and commercialisation benefits that will strengthen the drug programme - News - PharmaTimes

123
123
article thumbnail

Researchers develop novel chemosensor-based method for rapid detection of bacterial toxin

Express Pharma

A research team from Japan developed an innovative methodology to detect Lipopolysaccharide (LPS). Based on a novel fluorescent chemosensor, the proposed system detects the endotoxin in a matter of minutes, making it suitable for on-site testing in hospitals and pharma manufacturing facilities. LPS, largely known as “endotoxins”, is a molecule which is found in the outer membrane of Gram-negative bacteria, and can be very harmful to humans.

Hospitals 111
article thumbnail

Bristol Myers gets key FDA approval for bone marrow disease drug

BioPharma Dive

A broadened clearance for Reblozyl in myelodysplastic syndromes should help Bristol Myers offset the looming loss of revenue from top-selling medicines set to soon lose market exclusivity.

117
117
article thumbnail

Medicaid rebukes states for mistakenly disenrolling children

STAT

Medicaid warned states Wednesday that they could be mistakenly removing children from government insurance programs in a post-pandemic review of millions of enrollees. States may be unnecessarily disenrolling children from Medicaid or the Children’s Health Insurance Program because they are reviewing families as a whole despite there being a higher threshold to remove children from the programs.

361
361
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

How an AstraZeneca exec is leading the charge in the next immuno-oncology era

PharmaVoice

The pharma giant’s head of immuno-oncology is now charging toward the next step in the cancer fight with long-term survival and precision.

246
246
article thumbnail

SAEM Clinical Images Series: A Painful Swollen Digit

ALiEM - Pharm Pearls

A 50-year-old male with a history of polysubstance use disorder and poorly-controlled type 2 diabetes mellitus presents with left hand pain. One week ago, the patient sustained a macerating injury of the left distal middle digit. Since that time he has experienced worsening pain throughout the digit, now associated with diffuse swelling and discoloration.

Diabetes 130
article thumbnail

AstraZeneca’s Soliris approved in Japan for paediatric gMG patients

Pharma Times

The drug is the first to be approved in Japan to treat children and adolescents with& generalised myasthenia gravis - News - PharmaTimes

123
123
article thumbnail

Only 2 per cent medicines undergo quality control checks: Former IMA President

Express Pharma

HEAL Health recently organised a webinar titled ‘Demystifying the NMC Guidelines Conundrum’ against the backdrop of the recent postponement of the National Medical Commission (NMC) guidelines. The insights that emerged encompassed a spectrum of perspectives, shedding light on intricate challenges and potential solutions. Prof (Dr) J A Jayalal, Secretary General, Commonwealth Medical Association & Former National President, IMA , asserted, “An act perceived as draconian has gal

article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Sage, reeling from depression drug decision, to lay off 40% of workforce

BioPharma Dive

Two founding executives are leaving Sage alongside a major restructuring announced weeks after the FDA approved the medicine, Zurzuvae, for much narrower use than the company had hoped.

113
113
article thumbnail

STAT+: Departing Stanford president retracts two widely cited papers, against lead author’s wishes

STAT

After an expansive investigation found manipulated data and other issues with papers co-authored by Stanford’s now ex-president Marc Tessier-Lavigne , the prominent neuroscientist on Thursday retracted two studies published in the journal Science in 2001 — over the objection of a former postdoctoral researcher who played a leading role in both projects.

359
359
article thumbnail

Demand for weight loss drugs soars to nearly half of Americans

PharmaVoice

Drugs like the buzzy Ozempic are high on consumers’ radar — but lofty barriers to access remain.

246
246